Background Image
Table of Contents Table of Contents
Previous Page  67 / 88 Next Page
Information
Show Menu
Previous Page 67 / 88 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 28, No 4, July/August 2017

AFRICA

269

The second version of the roadmap draft was submitted to a

core group for internal review from October to December 2015.

In March 2016, a selected group of hypertension experts from

12 French-speaking countries met in Yaoundé to discuss the

algorithm and the draft.

15

Comments were received and the draft

was amended.

The task force reviewed the final draft of the roadmap in

Mexico in June 2016, which was then submitted for external

peer-review by three independent experts in hypertension and

policy development. The subsequent review was done by a group

of experts in cardiology, nephrology, primary care and research

(including clinical trials). Comments were reviewed and discussed

by the panel and incorporated into a revised and final document.

PASCAR searches and surveys on the status of

hypertension policy programmes and clinical

practice guidelines

From May to July 2015, an internal PASCAR survey was

conducted, aiming to determine which African countries ran

hypertension control programmes focusing on policy. Using the

Survey Monkey software tool,

16

national hypertension experts

from 40 countries were asked whether a hypertension policy

programme was operating in their country and could be judged as

being ‘dormant’, ‘not much active’, ‘active’, or ‘very much active’.

Among the responders (

n

=

127) representing 27 SSAcountries,

we noticed that up to 63.7% did not have a hypertension policy

programme or that it was dormant or not very active. This

regrettable situation highlights the importance of a continental

initiative to develop a hypertension policy to address BP control

from a population-wide and high-risk approach.

Evidence has shown that explicit clinical practice guidelines

(CPGs) do improve the care gap by providing practitioners and

health-service users with synthesised quality evidence regarding

decision-making.

17

In another PASCAR study, we assessed

the existence, development and use of national guidelines for

the detection and management of hypertension in the African

region, regardless of quality.

Between May and July 2015, CPGs for hypertension were

searched, using a scientifically developed search strategy.

Searches were done using Google and PubMed. Search terms

included (country name) AND (hypertension OR HTN OR

high blood pressure) AND (clinical practice guidelines OR

treatment guide). French, Portuguese and Spanish translations

were included in the search strategy.

Websites of ministries of health, national medical associations

and the WHO were hand-searched, authors were e-mailed, and

requests were sent on Afronets to obtain copies of CPGs for

hypertension. To be included in the search, the CPGs had to be

available and provided in full-text versions for assessment by the

review team, comprising three independent authors. CPGs from

Europe or South America or those that could not be obtained

were considered non-existent. Two national hypertension experts

were contacted for confirmation on countries for which we

could not find CPGs on hypertension. CPGs published in peer-

reviewed journals needed to be readily accessed by end-users.

E-mail messages were used for further clarification.

In Fig. 4, the 2015 map is presented of countries with clear

evidence of the existence of national guidelines for detection

and management of BP across Africa. Only 16 (25.8%) out of

62 countries had CPGs complying with our search criteria. No

evidence of CPGs on hypertension management could be found

for the other 46 (74.2%) countries. Given that the only existing

multinational expert recommendations for the management of

hypertension in Africa dates back to 2003 and has not been

updated since,

18

we concluded that there is a legitimate, pressing

need to support African ministries of health with a clear

hypertension roadmap.

PASCAR roadmap to decrease the burden of

hypertension in Africa

To reduce the incidence of CVD through treating hypertension

in the African region, it will be necessary to increase the rates of

detection, treatment and control of the disease. The 10 actions

that need to be undertaken by African ministries of health to

achieve a 25% control of hypertension in Africa by 2025 (Fig. 4)

are listed below and we include an explanation as to why (bullets)

and how (dashes) this needs to be done.

1. All NCD national programmes should additionally contain

a plan for the detection of hypertension.

The hypertension crisis has yet to receive an appropriate

response in SSA.

19

Incidence of hypertension increased by 67% since 1990

and was estimated to cause more than 500 000 deaths and

10 million years of life lost in 2010 in SSA.

20,21

Hypertension is the main cause of stroke, heart failure and

renal disease in SSA.

Stroke, which is a major complication of uncontrolled

hypertension, has increased to 46% since 1990 and essen-

tially affects breadwinners.

20

Failure to control hypertension and its economic repercus-

sions through revising health policies and services endan-

gers the economic prosperity of all African nations.

22

Fig 4.

2015 map of African countries with evidence of existing

clinical practice guidelines for hypertension manage-

ment and 10 actions to reduce the hypertension

burden in Africa